Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Farmakis

Showing results (201-210 of 297) with videos related to

Pageof 30
Sort By:
The American Journal of Cardiology|June 21, 2006
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failureStamatis Adamopoulos, John T Parissis, Efstathios K Iliodromitis, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 3, 2015
Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairmentPinelopi Rafouli-Stergiou, John T Parissis, Dimitrios Farmakis, et al.
Gynecologic Oncology|May 3, 2005
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceDimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos, et al.
International Journal of Cardiology|December 29, 2012
Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signalingKonstantinos Iliodromitis, Dimitrios Farmakis, Ioanna Andreadou, et al.
Cell Biochemistry and Biophysics|October 17, 2012
Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbitsEftychia Demerouti, Ioanna Andreadou, Ioanna-Katerina Aggeli, et al.
European Journal of Heart Failure|October 4, 2022
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-ReducedGerasimos Filippatos, Stefan D Anker, Javed Butler, et al.
Heart and Vessels|May 20, 2008
Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexesApostolos Karavidas, George Lazaros, Evangelos Matsakas, et al.
European Journal of Heart Failure|February 28, 2019
Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patientsKalliopi Keramida, Dimitrios Farmakis, Jose Bingcang, et al.
International Journal of Cardiology|October 9, 2012
Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failureSpiros P Kourouklis, Emmanouil Vagiakis, Ioannis A Paraskevaidis, et al.
European Heart Journal. Cardiovascular Imaging|March 7, 2015
EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of CardiologyPatrizio Lancellotti, Stefan D Anker, Erwan Donal, et al.
Pageof 30

Showing results (201-210 of 297) with videos related to

Sort By:
Pageof 30
The American Journal of Cardiology|June 21, 2006
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failureStamatis Adamopoulos, John T Parissis, Efstathios K Iliodromitis, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 3, 2015
Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairmentPinelopi Rafouli-Stergiou, John T Parissis, Dimitrios Farmakis, et al.
Gynecologic Oncology|May 3, 2005
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceDimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos, et al.
International Journal of Cardiology|December 29, 2012
Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signalingKonstantinos Iliodromitis, Dimitrios Farmakis, Ioanna Andreadou, et al.
Cell Biochemistry and Biophysics|October 17, 2012
Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbitsEftychia Demerouti, Ioanna Andreadou, Ioanna-Katerina Aggeli, et al.
European Journal of Heart Failure|October 4, 2022
Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR-ReducedGerasimos Filippatos, Stefan D Anker, Javed Butler, et al.
Heart and Vessels|May 20, 2008
Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexesApostolos Karavidas, George Lazaros, Evangelos Matsakas, et al.
European Journal of Heart Failure|February 28, 2019
Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patientsKalliopi Keramida, Dimitrios Farmakis, Jose Bingcang, et al.
International Journal of Cardiology|October 9, 2012
Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failureSpiros P Kourouklis, Emmanouil Vagiakis, Ioannis A Paraskevaidis, et al.
European Heart Journal. Cardiovascular Imaging|March 7, 2015
EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of CardiologyPatrizio Lancellotti, Stefan D Anker, Erwan Donal, et al.
Pageof 30